Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Benign prostatic hyperplasia (BPH), also called prostate gland enlargement, is a common condition that older men can suffer ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

Urination problems affect millions of men worldwide, often developing so gradually that many dismiss early warning signs.

VIJAYAWADA: Prashanth Hospital in Vijayawada introduced Resume Water Vapour Therapy for prostate problems, a first in the ...

In the OPD, every day, 5 in 10 men over 60 are complaining of urinary problems and are evaluated for BPH. Thus, an expert has ...

The presentation will be broadcast live and archived on the Company's website at www.profoundmedical.com under "Webcasts" in the Investors section. About Profound Medical Corp. Profound is a ...

Following the surgery, which lasted approximately two hours, Netanayhu was moved to the hospital's recovery room.

for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adult males on pharmacological therapy for benign prostatic hyperplasia ...